ENZO BIOCHEM INC Quarterly Other Assets, Noncurrent in USD from Q2 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Enzo Biochem Inc quarterly Other Assets, Noncurrent history and growth rate from Q2 2011 to Q1 2024.
  • Enzo Biochem Inc Other Assets, Noncurrent for the quarter ending April 30, 2024 was $591K, a 64.1% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $591K -$1.06M -64.1% Apr 30, 2024 10-Q 2024-06-13
Q4 2023 $645K -$980K -60.3% Jan 31, 2024 10-Q 2024-03-13
Q3 2023 $726K -$883K -54.9% Oct 31, 2023 10-Q 2023-12-15
Q2 2023 $5.75M +$4.44M +339% Jul 31, 2023 10-Q 2024-06-13
Q1 2023 $1.65M +$30K +1.86% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 $1.63M -$1K -0.06% Jan 31, 2023 10-Q 2023-03-20
Q3 2022 $1.61M +$217K +15.6% Oct 31, 2022 10-Q 2022-12-12
Q2 2022 $1.31M -$499K -27.6% Jul 31, 2022 10-K 2023-11-03
Q1 2022 $1.62M +$138K +9.33% Apr 30, 2022 10-Q 2022-06-09
Q4 2021 $1.63M +$245K +17.7% Jan 31, 2022 10-Q 2022-03-14
Q3 2021 $1.39M -$75K -5.11% Oct 31, 2021 10-Q 2021-12-15
Q2 2021 $1.81M +$423K +30.5% Jul 31, 2021 10-K 2022-10-14
Q1 2021 $1.48M -$422K -22.2% Apr 30, 2021 10-Q 2021-06-11
Q4 2020 $1.38M -$516K -27.2% Jan 31, 2021 10-Q 2021-03-16
Q3 2020 $1.47M -$985K -40.2% Oct 31, 2020 10-Q 2020-12-11
Q2 2020 $1.39M -$1.06M -43.4% Jul 31, 2020 10-K 2021-10-12
Q1 2020 $1.9M -$552K -22.5% Apr 30, 2020 10-Q 2020-06-09
Q4 2019 $1.9M -$818K -30.1% Jan 31, 2020 10-Q 2020-03-06
Q3 2019 $2.45M +$357K +17% Oct 31, 2019 10-Q 2019-12-10
Q2 2019 $2.45M +$963K +64.8% Jul 31, 2019 10-K 2020-10-19
Q1 2019 $2.45M +$972K +65.6% Apr 30, 2019 10-Q 2019-06-10
Q4 2018 $2.72M +$1.78M +189% Jan 31, 2019 10-Q 2019-03-11
Q3 2018 $2.1M +$1.76M +522% Oct 31, 2018 10-Q 2018-12-10
Q2 2018 $1.49M +$1.15M +346% Jul 31, 2018 10-K 2019-10-15
Q1 2018 $1.48M +$1.16M +354% Apr 30, 2018 10-Q 2018-06-11
Q4 2017 $940K +$608K +183% Jan 31, 2018 10-Q 2018-03-12
Q3 2017 $337K +$3K +0.9% Oct 31, 2017 10-Q 2017-12-07
Q2 2017 $333K -$3K -0.89% Jul 31, 2017 10-K 2018-10-15
Q1 2017 $326K -$31K -8.68% Apr 30, 2017 10-Q 2017-06-08
Q4 2016 $332K -$17K -4.87% Jan 31, 2017 10-Q 2017-03-13
Q3 2016 $334K -$4K -1.18% Oct 31, 2016 10-Q 2016-12-08
Q2 2016 $336K -$17K -4.82% Jul 31, 2016 10-K 2017-09-27
Q1 2016 $357K -$29K -7.51% Apr 30, 2016 10-Q 2016-06-08
Q4 2015 $349K -$36K -9.35% Jan 31, 2016 10-Q 2016-03-09
Q3 2015 $338K -$44K -11.5% Oct 31, 2015 10-Q 2015-12-08
Q2 2015 $353K -$32K -8.31% Jul 31, 2015 10-K 2016-10-13
Q1 2015 $386K +$42K +12.2% Apr 30, 2015 10-Q 2015-06-09
Q4 2014 $385K -$33K -7.9% Jan 31, 2015 10-Q 2015-03-12
Q3 2014 $382K +$12K +3.24% Oct 31, 2014 10-Q 2014-12-09
Q2 2014 $385K -$5K -1.28% Jul 31, 2014 10-K 2015-10-13
Q1 2014 $344K -$135K -28.2% Apr 30, 2014 10-Q 2014-06-09
Q4 2013 $418K -$13K -3.02% Jan 31, 2014 10-Q 2014-03-11
Q3 2013 $370K -$81K -18% Oct 31, 2013 10-Q 2013-12-10
Q2 2013 $390K -$17K -4.18% Jul 31, 2013 10-K 2014-10-09
Q1 2013 $479K +$45K +10.4% Apr 30, 2013 10-Q 2013-06-10
Q4 2012 $431K +$78K +22.1% Jan 31, 2013 10-Q 2013-03-12
Q3 2012 $451K +$96K +27% Oct 31, 2012 10-Q 2012-12-10
Q2 2012 $407K +$25K +6.55% Jul 31, 2012 10-K 2013-10-15
Q1 2012 $434K Apr 30, 2012 10-Q 2012-06-11
Q4 2011 $353K Jan 31, 2012 10-Q 2012-03-12
Q3 2011 $355K Oct 31, 2011 10-Q 2011-12-12
Q2 2011 $382K Jul 31, 2011 10-K 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.